MedPath

Effectiveness of a Smartphone App for Adolescent Obesity Management

Not Applicable
Conditions
Obesity
Physical Activity
Impaired Health
General Nutrition Disorder
Psychosocial Problem
Interventions
Behavioral: W82GO
Device: smartphone application
Registration Number
NCT01804855
Lead Sponsor
Children's University Hospital, Ireland
Brief Summary

Though face-to-face treatment of childhood obesity can be effective, it is time consuming and costly. This study will test whether treatment can be delivered via an Android app and whether such treatment reduces obesity.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
126
Inclusion Criteria
  • child aged between 12.0 and 17.0 years,
  • child BMI =/> 98th percentile,
  • first language is English (or fluent in English)
  • parent/s willing to participate in the programme with their child
  • completion of written informed consent and/or assent prior to any study-specific procedures
Exclusion Criteria
  • severe intellectual difficulties,
  • obesity secondary to genetic condition,
  • limitations to engaging in physical activity
  • use of medication known to effect body weight;
  • limitations to using a smartphone device
  • known family issues that would affect general compliance and attendance at follow-up visits.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
W82GOW82GOUsual face-to-face care as per the W82GO multidisciplinary treatment intervention (phase 1 for 6 weeks and phase 2 for 46 weeks).
Smartphonesmartphone applicationUsual care for Phase 1 of treatment. Treatment during Phase 2 of intervention using the Reactivate smartphone application only.
Primary Outcome Measures
NameTimeMethod
BMI Z score12 months

Z score calculated using LMS growth software

Secondary Outcome Measures
NameTimeMethod
Body Fat Mass12 months

Measured using Tanita Bioelectric impedance analyser

Physical activity12 months

Measured using Geneactive acclerometery

Laboratory tests12 months

Lipids; glucose; insulin; HbA1C; liver function

Safety12 months

Adverse effects will be monitored throughout the study and a full report at 12 months will be given.

Psychosocial health12 months

Measured using the Child Behaviour Check list

Trial Locations

Locations (1)

Temple Street Children's University Hospital

🇮🇪

Dublin, Ireland

© Copyright 2025. All Rights Reserved by MedPath